Edwards Lifesciences (EW) PT Raised to $98 at Credit Suisse Following Sapien Data
Tweet Send to a Friend
Credit Suisse analyst M. Keeler raised its price target on Outperform-rated Edwards Lifesciences (NYSE: EW) to $98.00 (from $88.00) after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
